Titomic Valuation

Is TTT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of TTT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate TTT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate TTT's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for TTT?

Key metric: As TTT is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for TTT. This is calculated by dividing TTT's market cap by their current revenue.
What is TTT's PS Ratio?
PS Ratio33.6x
SalesAU$7.70m
Market CapAU$258.52m

Price to Sales Ratio vs Peers

How does TTT's PS Ratio compare to its peers?

The above table shows the PS ratio for TTT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average7.8x
DGL DGL Group
0.3x8.1%AU$155.4m
HZR Hazer Group
24.7x57.5%AU$81.7m
CLV Clover
1.3x11.9%AU$81.0m
ANO Advance ZincTek
4.8xn/aAU$47.5m
TTT Titomic
33.6xn/aAU$258.5m

Price-To-Sales vs Peers: TTT is expensive based on its Price-To-Sales Ratio (33.6x) compared to the peer average (7.8x).


Price to Sales Ratio vs Industry

How does TTT's PS Ratio compare vs other companies in the AU Chemicals Industry?

14 CompaniesPrice / SalesEstimated GrowthMarket Cap
ORI Orica
1.2x4.0%US$5.77b
IPL Incitec Pivot
1.1x0.7%US$3.89b
NUF Nufarm
0.5x7.6%US$1.02b
DGL DGL Group
0.3x8.1%US$101.33m
TTT 33.6xIndustry Avg. 4.8xNo. of Companies14PS020406080100+
14 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: TTT is expensive based on its Price-To-Sales Ratio (33.6x) compared to the Australian Chemicals industry average (4.8x).


Price to Sales Ratio vs Fair Ratio

What is TTT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TTT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio33.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate TTT's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies